Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000416031 | SCV000493345 | uncertain significance | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001201348 | SCV000760070 | uncertain significance | Hereditary spastic paraplegia 8; Ritscher-Schinzel syndrome | 2023-12-07 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 808 of the WASHC5 protein (p.Ile808Val). This variant is present in population databases (rs144507279, gnomAD 0.03%). This missense change has been observed in individual(s) with hereditary spastic paraplegia (HSP) (PMID: 27957547). ClinVar contains an entry for this variant (Variation ID: 374553). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WASHC5 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000638546 | SCV000897418 | uncertain significance | Ritscher-Schinzel syndrome 1; Hereditary spastic paraplegia 8 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000416031 | SCV001714890 | uncertain significance | not provided | 2020-01-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848738 | SCV002104793 | uncertain significance | Hereditary spastic paraplegia | 2016-12-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000416031 | SCV003823681 | uncertain significance | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing |